Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 174,559 | 0.1% | 224,857 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 121,545 | 0.1% | 216,169 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 109,758 | 0.1% | 209,063 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 126,117 | 0.1% | 198,850 | 3/31/2025 |
| 2024 Q4 | 2/12/2025 | 127,118 | 0.1% | 177,008 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 172,667 | 0.2% | 164,251 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 156,782 | 0.2% | 149,170 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 127,880 | 0.2% | 132,864 | 3/31/2024 |
| 2023 Q4 | 2/8/2024 | 102,157 | 0.2% | 111,336 | 12/31/2023 |
| 2023 Q3 | 11/7/2023 | 87,014 | 0.2% | 105,733 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 69,995 | 0.1% | 97,413 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 74,795 | 0.2% | 91,028 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 59,239 | 0.2% | 82,223 | 12/31/2022 |
| 2022 Q3 | 11/1/2022 | 51,189 | 0.2% | 74,309 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 39,894 | 0.2% | 67,487 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 43,469 | 0.2% | 62,239 | 3/31/2022 |
| 2021 Q4 | 2/7/2022 | 35,529 | 0.1% | 56,656 | 12/31/2021 |
| 2021 Q3 | 11/4/2021 | 28,908 | 0.1% | 47,767 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 24,143 | 0.1% | 43,226 | 6/30/2021 |
| 2021 Q1 | 5/6/2021 | 17,833 | 0.1% | 37,691 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 15,932 | 0.1% | 32,978 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 17,171 | 0.2% | 30,675 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 16,348 | 0.2% | 26,213 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 8,381 | 0.1% | 17,163 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 6,326 | 0.1% | 17,137 | 12/31/2019 |
| 2014 Q2 | 8/5/2014 | 4,320 | 0.1% | 15,292 | 6/30/2014 |
| 2014 Q1 | 5/7/2014 | 4,589 | 0.1% | 15,281 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 3,878 | 0.1% | 14,269 | 12/31/2013 |